| Literature DB >> 26843853 |
Divya Persai1, Rajmohan Panda1, Ravi Kumar1, Andy Mc Ewen2.
Abstract
BACKGROUND: There are key gaps in the production and dissemination of evidence-based tobacco control research in developing countries. In India, limited research has been made to address and understand the function, constitution, thematic areas of research of a research and practice network in tobacco control. This study aimed to identify priority areas that were agreed by stakeholders for building tobacco research and practice network in India.Entities:
Year: 2016 PMID: 26843853 PMCID: PMC4739090 DOI: 10.1186/s12971-016-0067-x
Source DB: PubMed Journal: Tob Induc Dis ISSN: 1617-9625 Impact factor: 2.600
Survey tools for Round I & II
| Survey tool for Round I |
| What are the main factors holding back the formation of Tobacco control Research and practice Network (TRNI) in India? |
| What should be the priority of the TRNI? |
| What should be the focus of TRNI? |
| How TRNI can aid in implementation of tobacco control policies and program in the country? |
| How the quality of good tobacco control research and practice network can be assured? |
| What are the activities which can be undertaken in the TRNI? |
| How TRNI can financially sustain? |
| How TRNI can help in your research and practice? |
| Survey tool for Round II |
| Below, is a list of the focus areas identified for tobacco research and practice network. Please rate each of the areas in terms of its value in developing a Tobacco Research and Practice Network in India. |
| How can Tobacco Research and Practice Network influence evidence-based implementation of tobacco control policies and programs? |
| What are the main factors holding back research dissemination & knowledge sharing in research pertaining to tobacco control in India? |
| How can the TRNI address such issues? |
| According to you, who should be the part of tobacco research network in India? |
| What activities can enhance information exchange between researchers in the Tobacco Research and Practice Network |
| How TRNI would benefit researchers? |
Three-stage process for establishing consensus on research priorities
| Stage 1 | Stage 2 | Stage3 |
|---|---|---|
| Topic identification | Stakeholder survey | Priority consensus |
| Topics identified through literature review | Survey instrument was developed and refined as follows: | Consensus formed by expert panel (Delphi process) ( |
| Result | Result | Result |
| Topics were incorporated into survey instrument | Stakeholder survey data provided foundation for consensus formation | Research priorities finalized and disseminated |
Experts consensus in Delphi study
| Strong consensus | Consensus (agreement in %) | Inter quartile range |
|---|---|---|
| Focus of TRNI | >75 % | 1 |
| Tobacco cessation | >75 % | 1 |
| Economic research | >75 % | 1 |
| Implementation of tobacco control policy | ||
| Sharing best practices | >75 % | 1 |
| Advocacy | >75 % | 1 |
| Financial sustainability | ||
| Funds from government | >75 % | 1 |
| Network members | ||
| Government | >75 % | 1 |
| NGOs | >75 % | 1 |
| Academia | >75 % | 0.25 |
| Factors holding back research dissemination | ||
| Lack of funds | 0 | |
| Benefits of the network | ||
| Information sharing | >75 % | 1 |
| Technical support | >75 % | 1 |
| Moderate consensus | ||
| Focus of TRNI | ||
| Disease research | 60–74 % | 1 |
| Implementation of tobacco control policy | ||
| Consensus building | 60–74 % | 2 |
| Establishing standard protocols | 60–74 % | 1 |
| Factors holding back research | ||
| Lack of technical expertise | 60–74 % | 2 |
| Financial sustainability | ||
| Funds from International organizations | 60–74 % | 1 |
| Involvement of private sector and pharmaceutical companies | ||
| Private sector should be involved with caution | 60–74 % | |
| Benefits of the network | ||
| Evidence-based policy implementation | 60–74 % | |
| No consensus | ||
| Factors holding back research | ||
| Lack of emphasis on tobacco control | <60 % | 2 |
| Lack of platform/forum | <60 % | 2 |
| Financial sustainability | ||
| Nominal membership fees | <60 % | 3 |
| Involvement of private sector and pharmaceutical companies | ||
| Private sector can be in involved in the network | <60 % | 2 |
| Pharmaceutical companies should be involved with caution | <60 % | 2 |
| Private sector and pharmaceutical companies should not be involved in the network | <60 % | 2 |
| Benefits of the network | ||
| Consensus building | <60 % | 2 |
Fig 1Network’s Role in implementation of tobacco control policies and program
Fig 2Benefits of research and practice network in tobacco control